American International Group, Inc. Theseus Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$2.12 - $4.18 $84 - $167	-40 Reduced 0.4%	10,060 $40,000
Q3 2023 Nov 13, 2023	BUY	$2.66 - $10.04 $954 - $3,604	359 Added 3.69%	10,100 $27,000
Q2 2023 Aug 04, 2023	BUY	$7.28 - $11.82 $11,211 - $18,202	1,540 Added 18.78%	9,741 $90,000
Q1 2023 May 12, 2023	BUY	$5.21 - $14.05 $854 - $2,304	164 Added 2.04%	8,201 $72,000
Q4 2022 Feb 10, 2023	SELL	$4.69 - $8.36 $136 - $242	-29 Reduced 0.36%	8,037 $40,000

Q3 2022 Nov 14, 2022	BUY	$5.7 - $8.68 $649 - $989	114 Added 1.43%	8,066 $47,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $14.05 $11,279 - $31,443	2,238 Added 39.17%	7,952 $44,000
Q1 2022 May 13, 2022	SELL	$8.75 - $14.51 $3,517 - $5,833	-402 Reduced 6.57%	5,714 $66,000
Q4 2021 Feb 11, 2022	BUY	$8.98 - $20.09 $54,921 - $122,870	6,116 New	6,116 $78,000

1.06M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.